Skip to Main Content

Here you can browse the complete list of projects for PLCO that have already been approved.

Data-Only Studies
Biospecimen Studies

Results: 950 (Showing 1 to 20) — Export these results

Name Principal Investigator Institution Study Date Approved Project ID
A Comparison Between Multi Classification Algorithms on PLCO Colorectal Cancer Dataset Bawer Berwary Van Yuzuncu Yil University PLCO Nov 14, 2019 PLCO-533
Predicting Cancer diagnosis based on preliminary screenings Jonathan Mendoza Independent PLCO Nov 14, 2019 PLCO-532
Link-based survival additive models with mixed types of censoring. Giampiero Marra University College London PLCO Nov 14, 2019 PLCO-538
Data mining study on clinical and imaging data for assessing cancer risk and estimating outcome Shandong Wu University of Pittsburgh, Department of Radiology PLCO Nov 14, 2019 PLCOI-519
Predicting lung cancer recurrence with machine learning Flavio Calmon Harvard University PLCO Nov 13, 2019 PLCOI-522
Machine Learning to select patients benefiting from prostate cancer screening Jean-Emmanuel Bibault Laboratory of Artificial Intelligence in Medicine and Biomedical Physics, Stanford University PLCO Nov 6, 2019 PLCO-541
Exploration of deep learning-based model's lung cancer screening capabilities. Manwoo Lee Samsung Electronics PLCO Nov 4, 2019 PLCOI-537
Quantitative analysis of tissue morphology and biomarkers with convolutional neural networks for improve prognostics of prostate cancer Geert Litjens Radboud University Medical Center PLCO Nov 4, 2019 PLCOI-540
“Development of a probabilistic network for clinical pathways based on patient cohort characteristics, outcome-indicators and clinical workflow analysis to create artificial patients with prostatic adenocarcinoma” Andrea Riedel Institute for general practitioners PLCO Nov 4, 2019 PLCO-535
Evaluation of Patients Data using AI techniques and It's Application in Pancreatic Cancer Differential Diagnosis Wanessa Sena Federal Institute of Pernambuco PLCO Nov 4, 2019 PLCO-539
Inflammatory potential of diet and risk of ovarian cancer by menopausal status in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Zhuyue Li West China Hospital PLCO Nov 4, 2019 PLCO-536
Dietary Inflammatory Index and risk of differentiated thyroid cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Li Chen Department of the Endocrine and Breast Surgery, The First Affiliated hospital of Chongqing Medical university PLCO Nov 4, 2019 PLCO-543
Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype Jennifer Davis UT MD Anderson Cancer Center PLCO Oct 29, 2019 2018-0009
Individualized treatment decisions for prostate cancer using prostate cancer specific and other-cause mortality predictors Matthew Schipper University of Michigan PLCO Oct 10, 2019 PLCO-512
Tobacco smoking is associated with increased tumor grade and stage and grade along with the mucinous carcinoma histopathologic type. Rodger Rothenberger University of Cincinnati PLCO Oct 10, 2019 PLCO-534
Ethnic differences in colorectal cancer incidence: the role of lifestyle risk factors Ivana Kulhanova Faculty of Science, Charles University PLCO Oct 10, 2019 PLCO-507
Serum Testosterone and Subsequent Risk of Urologic and Non-Urologic Cancer Joshua Halpern Northwestern University Feinberg School of Medicine PLCO Oct 10, 2019 PLCO-528
Use of deep learning to predict response of treatment for late stage lung cancer patients. Monika Mehta SGInnovate - Entrepreneur First PLCO Oct 8, 2019 PLCOI-531
Pan-cancer analyses of imaging-clinical phenotype associations Kun-Hsing Yu Harvard Medical School PLCO Oct 8, 2019 PLCOI-523
Assessing the interrelationship between different breast cancer diagnostic parameters and their overall effects on patient survival using machine learning tools Balint Balint University of Debrecen PLCO Oct 8, 2019 PLCO-524